Potential Adverse Effects of Discontinuing Psychotropic Drugs: Part 4: Benzodiazepine, Glutamate, Opioid, and Stimulant Drugs
Abstract
For nurses in clinical practice, understanding the pharmacology of drugs their patients take is relevant to understanding their therapeutic uses, side effect profiles, and adverse discontinuation effects. In this article, the last of a four-part series, the discontinuation effects of the following psychotropic drugs are described: benzodiazepine drugs (which have hypnotic, anti-anxiety, and anticonvulsant effects), non-benzodiazepine drugs (used for insomnia), glutamate-modulating drugs, opioid receptor agonist drugs (used as analgesics for the treatment of various pain conditions), and stimulant drugs. Serious adverse effects are likely to occur only after abrupt discontinuation of benzodiazepine drugs, and they should almost always be tapered. Prominent discontinuation effects are seen with opioid and stimulant drugs, but these are usually not serious. Tapering medication, rather than abruptly stopping them, can avoid or minimize the potential adverse discontinuation effects associated with most psychotropic drugs.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
Withdrawal symptoms can occur on the cessation of both first- and second-generation antipsychotics.
“Although not widely recognized, withdrawal symptoms can occur on the cessation of both first- and second-generation antipsychotics (FGAs and SGAs).17,20,23”
From A Method for Tapering Antipsychotic Treatment That May Minimize the Risk of Relapse (2021) · cites this paper as [17]
Cites
Long-term Therapeutic Use of Benzodiazepines: I. Effects of Abrupt Discontinuation
Rickels, K. (1990) · Archives of General Psychiatry · doi:10.1001/archpsyc.1990.01810220015002 · Cited by 332 · see citing works
Clinical risk following abrupt and gradual withdrawal of maintenance neuroleptic treatment
Viguera, A. C. (1997) · Archives of General Psychiatry · doi:10.1001/archpsyc.1997.01830130055011 · Cited by 246 · see citing works
Pharmacology and pharmacokinetics of milnacipran
Puozzo, C., Panconi, E., & Deprez, D. (2002) · International Clinical Psychopharmacology · doi:10.1097/00004850-200206001-00004 · Cited by 242 · see citing works
Outcome After Rapid vs Gradual Discontinuation of Lithium Treatment in Bipolar Disorders
Faedda, G. L. (1993) · Archives of General Psychiatry · doi:10.1001/archpsyc.1993.01820180046005 · Cited by 239 · see citing works
Withdrawal of Anticonvulsant Drugs in Patients Free of Seizures for Two Years
Callaghan, N., Garrett, A., & Goggin, T. (1988) · New England Journal of Medicine · doi:10.1056/nejm198804143181502 · Cited by 177 · see citing works
Chouinard, G., & Chouinard, V.-A. (2008) · Psychotherapy and Psychosomatics · doi:10.1159/000112883 · Cited by 168 · see citing works
Discontinuing lithium maintenance treatment in bipolar disorders: risks and implications
Baldessarini, R. J., Tondo, L., & Viguera, A. C. (1999) · Bipolar Disorders · doi:10.1034/j.1399-5618.1999.10106.x · Cited by 152 · see citing works
The SSRI discontinuation syndrome
Haddad, P. M. (1998) · Journal of Psychopharmacology · doi:10.1177/026988119801200311 · Cited by 123 · see citing works
Illness risk following rapid versus gradual discontinuation of antidepressants
Baldessarini, R. J., Tondo, L., Ghiani, C., & Lepri, B. (2010) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2010.09060880 · Cited by 123 · see citing works
Case report of neuroleptic malignant syndrome associated with withdrawal from amantadine
Simpson, D. M., & Davis, G. C. (1984) · American Journal of Psychiatry · doi:10.1176/ajp.141.6.796 · Cited by 106 · see citing works
Clozapine Withdrawal_Emergent Dystonias and Dyskinesias
Ahmed, S., Chengappa, K. N. R., Naidu, V. R., Baker, R. W., Parepally, H., & Schooler, N. R. (1998) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v59n0906 · Cited by 105 · see citing works
Catatonia After Benzodiazepine Withdrawal
Rosebush, P. I., & Mazurek, M. F. (1996) · Journal of Clinical Psychopharmacology · doi:10.1097/00004714-199608000-00007 · Cited by 89 · see citing works
LAGO, J. A., & Kosten, T. R. (1994) · Addiction · doi:10.1111/j.1360-0443.1994.tb03746.x · Cited by 86 · see citing works
Benzodiazepine Withdrawal Syndrome: A Literature Review and Evaluation
Mackinnon, G. L., & Parker, W. A. (1982) · The American Journal of Drug and Alcohol Abuse · doi:10.3109/00952998209002608 · Cited by 81 · see citing works
Venlafaxine-tramadol similarities
Markowitz, J. S., & Patrick, K. S. (1998) · Medical Hypotheses · doi:10.1016/s0306-9877(98)90112-8 · Cited by 69 · see citing works
Benzodiazepine Withdrawal - Induced Catatonia
Deuschle, M. (2001) · Pharmacopsychiatry · doi:10.1055/s-2001-15188 · Cited by 62 · see citing works
Antidepressant-Withdrawal Mania: A Critical Review and Synthesis of the Literature
Andrade, C. (2004) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v65n0716 · Cited by 49 · see citing works
Neuroleptic malignant syndrome after neuroleptic discontinuation
Amore, M., & Zazzeri, N. (1995) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/0278-5846(95)00269-3 · Cited by 42 · see citing works
Changes in psychopathology and dyskinesia after neuroleptic withdrawal in a double-blind design
Dixon, L. B., Thaker, G. K., Conley, R. R., Ross, D. E., Cascella, N. G., & Tamminga, C. A. (1993) · Schizophrenia Research · doi:10.1016/0920-9964(93)90061-m · Cited by 38 · see citing works
Clonazepam Withdrawal-Induced Catatonia
Brown, M., & Freeman, S. A. (2009) · Psychosomatics · doi:10.1176/appi.psy.50.3.289 · Cited by 34 · see citing works
Aripiprazole Induced Acute Dystonia After Discontinuation of a Stimulant Medication
McLaren, J., Cauble, S., & Barnett, R. J. (2010) · Journal of Clinical Psychopharmacology · doi:10.1097/jcp.0b013e3181c92eb2 · Cited by 26 · see citing works
Withdrawal of Anticonvulsant Drugs in Seizure-Free Epileptic Patients
Wallis, W. (1987) · Clinical Neuropharmacology · doi:10.1097/00002826-198710000-00004 · Cited by 21 · see citing works
Atypical antipsychotic withdrawal dyskinesia in 4 patients with mood disorders
Urbano, M., Spiegel, D., & Rai, A. (2007) · Journal of Clinical Psychopharmacology · doi:10.1097/jcp.0b013e31815a5870 · Cited by 17 · see citing works
Bobolakis, I. (2000) · Journal of Clinical Psychopharmacology · doi:10.1097/00004714-200004000-00033 · Cited by 15 · see citing works
Reversible withdrawal dyskinesia associated with quetiapine
Michaelides, C., Thakore‐James, M., & Durso, R. (2005) · Movement Disorders · doi:10.1002/mds.20427 · Cited by 15 · see citing works
Discontinuing an Antidepressant? Tapering Tips to Ease Distressing Symptoms
Muzina, D. J. (2010) · Current psychiatry · Cited by 6 · see citing works
Flagged first, then by citations
Cited by
Sorted by citations
A Method for Tapering Antipsychotic Treatment That May Minimize the Risk of Relapse
Horowitz, M. A., Jauhar, S., Natesan, S., Murray, R. M., & Taylor, D. (2021) · Schizophrenia Bulletin · doi:10.1093/schbul/sbab017 · Cited by 157 · see citing works
Discontinuation of psychotropic medication: a synthesis of evidence across medication classes.
Vinkers, C. H., Kupka, R. W., Penninx, B. W., Ruhé, H. G., van Gaalen, J. M., van Haaren, P. C. F., Schellekens, A. F. A., Jauhar, S., Ramos-Quiroga, J. A., Vieta, E., et al. (2024) · Molecular Psychiatry · doi:10.1038/s41380-024-02445-4 · Cited by 51 · see citing works
Experiencing antipsychotic discontinuation: results from a survey of <scp>A</scp>ustralian consumers
Salomon, C., Hamilton, B., & Elsom, S. (2014) · Journal of Psychiatric and Mental Health Nursing · doi:10.1111/jpm.12178 · Cited by 25 · see citing works
Eserian, J. K., Blanco, V. P., Mercuri, L. P., Matos, J. D. R., & Galduróz, J. C. F. (2023) · Psychiatry Research · doi:10.1016/j.psychres.2023.115537 · Cited by 15 · see citing works
- Authors
- Howland, R. H.
- Affiliations
- University of Pittsburgh (US)
- Corresponding author
- Robert H. Howland
- ORCID
- Robert H. Howland
- Venue
- Journal of Psychosocial Nursing and Mental Health Services
- Publisher
- SLACK, Inc.
- Published
- 2010-09
- Volume
- 48
- Issue
- 9
- Pages
- 11-14
- ISSN
- 0279-3695 (ISSN-L)
- 1938-2413
- OpenAlex
- W1964985503
- Cited by
- 38
- References
- 26
- Citations by year
- 2025: 3 · 2024: 3 · 2023: 3 · 2021: 4 · 2018: 5 · 2017: 4 · 2016: 1 · 2015: 1 · 2014: 5 · 2013: 5 · 2012: 2
- FWCI
- 1.15
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Journal of Psychosocial Nursing and Mental Health Services (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Geriatrics and Gerontology › Pharmaceutical Practices and Patient Outcomes
- Health Sciences › Medicine › Epidemiology › Substance Abuse Treatment and Outcomes
- Health Sciences › Medicine › Anesthesiology and Pain Medicine › Pain Management and Opioid Use
- Keywords
- psychotropic drugs, drug discontinuation, adverse effects, benzodiazepines, non-benzodiazepine hypnotics, insomnia, opioid agonists, analgesics, stimulants, tapering, abrupt discontinuation, nursing pharmacology
- MeSH terms
- Central Nervous System Stimulants, Analgesics, Opioid, Benzodiazepines, Drug Administration Schedule, Humans, Hypnotics and Sedatives, Psychiatric Nursing, Psychotropic Drugs, Substance Withdrawal Syndrome, Excitatory Amino Acid Agents
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review